ID: ALA2047234

Max Phase: Preclinical

Molecular Formula: C25H30N2O8S

Molecular Weight: 428.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C(=O)C2CCN([C@@H]3CN(C(=O)c4cccs4)CC[C@H]3O)CC2)cc1.O=C(O)C(=O)O

Standard InChI:  InChI=1S/C23H28N2O4S.C2H2O4/c1-29-18-6-4-16(5-7-18)22(27)17-8-11-24(12-9-17)19-15-25(13-10-20(19)26)23(28)21-3-2-14-30-21;3-1(4)2(5)6/h2-7,14,17,19-20,26H,8-13,15H2,1H3;(H,3,4)(H,5,6)/t19-,20-;/m1./s1

Standard InChI Key:  PGNJQKHFHXVREE-GZJHNZOKSA-N

Associated Targets(Human)

Vesicular acetylcholine transporter 269 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sigma-1 receptor 3326 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 428.55Molecular Weight (Monoisotopic): 428.1770AlogP: 2.93#Rotatable Bonds: 5
Polar Surface Area: 70.08Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.14CX LogP: 2.19CX LogD: 2.00
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.74Np Likeness Score: -1.01

References

1. Tu Z, Wang W, Cui J, Zhang X, Lu X, Xu J, Parsons SM..  (2012)  Synthesis and evaluation of in vitro bioactivity for vesicular acetylcholine transporter inhibitors containing two carbonyl groups.,  20  (14): [PMID:22739089] [10.1016/j.bmc.2012.05.045]

Source